Hepatitis C Educational Webinar For Prescribers Occurs March 6

Published on

HHSC contracted with drug manufacturer AbbVie to improve awareness, screening, diagnosis, and treatment of the Hepatitis C Virus (HCV) for Medicaid clients. HCV is a liver infection caused by a virus and often develops into a long-term or chronic illness. If untreated, HCV can cause significant damage to the body, such as liver cancer and cirrhosis.

In support of the HHSC initiative to improve awareness, screening, diagnosis, and treatment of Hepatitis C Virus (HCV) for Medicaid clients, AbbVie will host an educational event for prescribers called Treating Hepatitis C with Mavyret in your Practice on March 6. Registration ends Friday, March 1. MCOs are encouraged to share information about this event with your provider network.

Treating Hepatitis C with Mavyret in your Practice (PDF)

  • Wednesday, March 6, 2024
  • 12:15 p.m., Central Time
  • 11:15 a.m., Mountain Time

Click here to register.